Evaluation of Adverse Drug Reactions Associated with Proton Pump Inhibitors: A Prospective Observational Study
Journal of Pharmacy and Bioallied Sciences · 2026-10 · 18 (4) · 362-364
DOI: 10.4103/jpbs.jpbs_281_26 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy and Bioallied Sciences, online erschienen am 17.11.2026. Verfasst von Sonali B. Rode und 5 weiteren Autor:innen. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
A BSTRACT Background: Proton pump inhibitors (PPIs) are widely prescribed and generally well tolerated, yet unnecessary or prolonged exposure may increase the likelihood of adverse drug reactions (ADRs).
Objective
To evaluate the pattern, frequency, severity, and clinical predictors of ADRs among adults receiving PPIs.
Methods
In this prospective observational model study, 240 adults receiving pantoprazole, omeprazole, esomeprazole, or rabeprazole were followed for 6 months. Suspected ADRs were assessed clinically and, when appropriate, by laboratory testing; causality and severity were categorized using standard pharmacovigilance scales.
Results
The mean age was 48.6 ± 15.2 years and 55.0% were men. Fifty-two participants (21.7%) experienced at least one suspected ADR, accounting for 61 events. Headache (18.0% of events), diarrhea (14.8%), abdominal discomfort (13.1%), nausea (11.5%), and constipation (9.8%) were most frequent. Five patients (2.1%) developed hypomagnesemia. ADRs were more common in patients aged ≥60 years than in younger adults (31.6% vs. 17.1%, P = 0.009), in those receiving PPIs for >6 months (35.6% vs. 13.7%, P < 0.001), and in those with polypharmacy (33.3% vs. 16.0%, P = 0.002). ADR rates did not differ significantly among individual PPIs ( P = 0.97). Most events were mild (70.5%) or moderate (27.9%); one severe event occurred and no fatal event was observed.
Conclusion
Suspected PPI-related ADRs were predominantly nonserious, but longer exposure, older age, and polypharmacy were associated with higher occurrence.
Zitieren
APA
Rode, S. B., Jogdand, K. S., Salankar, H. V., Koyani, B., Shah, S. H., & Patel, J. (2026). Evaluation of Adverse Drug Reactions Associated with Proton Pump Inhibitors: A Prospective Observational Study. Journal of Pharmacy and Bioallied Sciences, 18(4), 362-364. https://doi.org/10.4103/jpbs.jpbs_281_26
Vancouver
Rode SB, Jogdand KS, Salankar HV, Koyani B, Shah SH, Patel J. Evaluation of Adverse Drug Reactions Associated with Proton Pump Inhibitors: A Prospective Observational Study. Journal of Pharmacy and Bioallied Sciences. 2026;18(4):362-364. doi:10.4103/jpbs.jpbs_281_26
BibTeX
@article{Rode2026,
author = {Rode, Sonali B. and Jogdand, Keerti Sopanrao and Salankar, Harsh Vidyadhar and Koyani, Bhargav and Shah, Snehal Himmatlal and Patel, Jitendra},
title = {Evaluation of Adverse Drug Reactions Associated with Proton Pump Inhibitors: A Prospective Observational Study},
journal = {Journal of Pharmacy and Bioallied Sciences},
year = {2026},
volume = {18},
number = {4},
pages = {362--364},
doi = {10.4103/jpbs.jpbs_281_26}
}
EUVIMED